Registration - Amendment
MEHLMAN CONSULTING, INC. for VIRTUS PHARMACEUTICALS LLC
Client
Income
—
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Issues related to generic drugs and the FDA. FDA and related agencies appropriations funding for Fiscal Year 2018.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAUREN ARONSON New | — |
| DAVID CASTAGNETTI New | — |
| MICHAEL COLLINS New | — |
| SAGE EASTMAN New | — |
| ELISE FINLEY PICKERING New | — |
| SOHINI GUPTA New | — |
| CONSTANTINE HINGSON New | — |
| BRUCE MEHLMAN New | — |
| MICHAEL ROBINSON New | — |
| DEAN ROSEN New | — |
| DAVID R THOMAS New | — |
| CHARLES WOOTERS New | — |
Pharmacy PHA
Issues related to generic drugs and the FDA. FDA and related agencies appropriations funding for Fiscal Year 2018.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAUREN ARONSON New | — |
| DAVID CASTAGNETTI New | — |
| MICHAEL COLLINS New | — |
| SAGE EASTMAN New | — |
| ELISE FINLEY PICKERING New | — |
| SOHINI GUPTA New | — |
| CONSTANTINE HINGSON New | — |
| BRUCE MEHLMAN New | — |
| MICHAEL ROBINSON New | — |
| DEAN ROSEN New | — |
| DAVID R THOMAS New | — |
| CHARLES WOOTERS New | — |
Health Issues HCR
Issues related to generic drugs and the FDA. FDA and related agencies appropriations funding for Fiscal Year 2018.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAUREN ARONSON New | — |
| DAVID CASTAGNETTI New | — |
| MICHAEL COLLINS New | — |
| SAGE EASTMAN New | — |
| ELISE FINLEY PICKERING New | — |
| SOHINI GUPTA New | — |
| CONSTANTINE HINGSON New | — |
| BRUCE MEHLMAN New | — |
| MICHAEL ROBINSON New | — |
| DEAN ROSEN New | — |
| DAVID R THOMAS New | — |
| CHARLES WOOTERS New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.